Wed.Oct 16, 2024

article thumbnail

Exelixis stock rises as key drug Cabometyx withstands patent challenge

Fierce Pharma

A federal judge in Delaware has ruled in favor of Exelixis in its Cabometyx patent fight with MSN Laboratories, effectively pushing the earliest generic entry out to 2030. | A federal judge in Delaware has ruled in favor of Exelixis in its Cabometyx patent fight with MSN Laboratories, effectively pushing the earliest generic entry out to 2030.

272
272
article thumbnail

Wearable Tumor-Zapping Medical Device Wins FDA Approval for Lung Cancer

MedCity News

The FDA approved Novocure medical device Optune Luna as a treatment for advanced cases of non-small cell lung cancer. The wearable technology delivers electrical fields that kill cancer cells. The post Wearable Tumor-Zapping Medical Device Wins FDA Approval for Lung Cancer appeared first on MedCity News.

Medical 125
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

With Gilead coming fast, GSK bolsters case for long-acting HIV PrEP drug Apretude

Fierce Pharma

With Gilead sprinting to a likely approval next year for its long-acting pre-exposure | With GSK girding for competition from Gilead Sciences, the company has presented strong results from three real-world studies of its bi-monthly injection for HIV prevention.

article thumbnail

Nurturing the Nurturers: The Role of Parental and Caregiver Wellness in Supporting Children’s Mental Health

MedCity News

Healthcare providers play a critical role in helping caregivers recognize potential imbalances. Encouraging caregivers to access resources for self-care and respite isn’t just a nicety, it’s a clinical necessity. The post Nurturing the Nurturers: The Role of Parental and Caregiver Wellness in Supporting Children’s Mental Health appeared first on MedCity News.

article thumbnail

AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

article thumbnail

Amid strike threat, Sanofi promises consumer health group will stay 'anchored' in France

Fierce Pharma

As Sanofi moves forward with talks to potentially sell a 50% stake its consumer health unit Opella, fears of job cuts and drug shortages have prompted a call for industrial action in the company’s | French unions have urged Sanofi employees to strike from the start of their shifts Thursday in a move covering “the whole of France." The industrial action hinges on concerns over job cuts and drug shortages tied to Sanofi's potential consumer health stake sale.

Sales 256
article thumbnail

12 Compelling Sessions to Check Out at HLTH 2024

MedCity News

HLTH 2024, scheduled for October 20-23 at the Venetian Expo Center in Las Vegas, will highlight the shifting landscape of healthcare innovation in many different settings. Register today! The post 12 Compelling Sessions to Check Out at HLTH 2024 appeared first on MedCity News.

More Trending

article thumbnail

Want to launch a blockbuster? An AstraZeneca exec breaks it down.

PharmaVoice

Even drugs with “blockbuster potential” often fall short of expectations. Here’s what can help a new medication pass the $1 billion mark.

Medical 115
article thumbnail

Scilex Holding looks to separate Scilex Pharma through potential spinout, IPO

Fierce Pharma

Scilex Pharma may soon flee the nest after its parent company Scilex Holding’s board of directors granted permission to explore routes to maximize the company’s value. | Scilex Pharma may soon flee the nest after its parent company Scilex Holding’s board of directors granted permission to explore alternative routes for the drugmaker.

Pharma 216
article thumbnail

Evolving Markets, Innovative Solutions: The Rise of Specialty VBC

MedCity News

This new approach is helping payors and providers unlock new value from their VBC initiatives while offering more effective and condition-specific treatment for patients. The post Evolving Markets, Innovative Solutions: The Rise of Specialty VBC appeared first on MedCity News.

Marketing 110
article thumbnail

NIH study backs Bavarian Nordic mpox jab for adolescents

pharmaphorum

NIH study finds Bavarian Nordic's mpox vaccine is effective in adolescents, a particularly vulnerable group amid the ongoing outbreak

116
116
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

How One Investor Views the Future of Healthcare AI

MedCity News

In the future, healthcare AI startups that offer multimodal models may have an easier time raising venture capital than healthcare AI companies that don’t, according to Morgan Cheatham, vice president at Bessemer Venture Partners. The post How One Investor Views the Future of Healthcare AI appeared first on MedCity News.

article thumbnail

Pfizer sticks $1.5bn on Triana's molecular glue tech

pharmaphorum

Pfizer partners with US biotech Triana Biomedicines in a deal focusing on molecular glue degraders that could be worth $1.

115
115
article thumbnail

Oshi Health Secures $60M To Scale Virtual Digestive Care

MedCity News

Oshi Health’s $60 million Series C funding round was led by Oak HC/FT and included participation from existing investors Bessemer Venture Partners, Flare Capital Partners, Frist Cressey Ventures, CVS Health Ventures and Takeda Digital Ventures. The post Oshi Health Secures $60M To Scale Virtual Digestive Care appeared first on MedCity News.

103
103
article thumbnail

Unifying and Contextualizing Drug Discovery Data

PharmaTech

Collecting and curating R&D data are increasingly crucial tasks for achieving the full benefits of advanced analytics.

95
article thumbnail

How to Prove Marketing Value: Demonstrate Content ROI and Contribution to Sales

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

article thumbnail

Access to genomic surveillance: Open science and public health

pharmaphorum

The pandemic served as a catalyst for a revolution in genomic surveillance for tracking pathogens. The technology proved vital in aiding understanding of the evolution of and spread of virus in real time to inform public health measures, ultimately accelerating drug and vaccine development.

69
article thumbnail

AAV gene therapy manufacturing gets £1.4m boost

European Pharmaceutical Review

Three industry partners have agreed to collaborate to develop an intensified perfusion process for manufacturing adeno-associated virus (AAV) vectors, leading to improved gene therapy production. The two-year project is supported by a £1.4 million grant through the Innovate UK Transforming Medicines Manufacturing (TMM) Programme, and involves the Cell and Gene Therapy (CGT) Catapult , Pharmaron Biologics (UK) Ltd and Complement Therapeutics.

article thumbnail

Wave surges on first RNA editing data in humans

pharmaphorum

Shares in Wave Life Sciences rose by 74% after it reported clinical data with a pioneering RNA-editing therapy for alpha-1 antitrypsin deficiency (AATD)

73
article thumbnail

HBC Immunology shares promising results for prostate cancer co-therapy

PharmaTimes

There are around 55,100 new prostate cancer cases in the UK every year

95
article thumbnail

Optimizing Clinical Supply Strategy: Navigating Challenges & Finding Your Ideal Model

article thumbnail

FDA set to decide on GSK's gepotidacin antibiotic in March

pharmaphorum

The FDA starts priority review of GSK's gepotidacin, vying to become the first new-class antibiotic for uncomplicated urinary tract infections in over 20 years

FDA 75
article thumbnail

Patient Engagement Throughout the Entire Product Lifecycle (October 2024)

PharmExec

In the pharmaceutical industry, patient engagement should be centered in health education, communication, and strategy during drug discovery and throughout the product lifecycle. Cheryl Lubbert, CEO of Reverba, discusses the importance of a patient-first mindset in the industry.

article thumbnail

MeiraGTx plans to take Parkinson's gene therapy into phase 3

pharmaphorum

Armed with data from a small phase 1/2 bridging study, MeiraGTx is preparing to take its gene therapy for Parkinson's disease into a pivotal trial.

73
article thumbnail

Havas Lynx debuts global health influencer offering

PM360

The service includes more than 50 healthcare influencers in 14 therapeutic areas who will develop relevant and engaging content for clients. by Jack O’Brien, MM+M October 15, 2024 Share article on Twitter Share article on Facebook Share article on LinkedIn (Photo credit: Getty Images/Ignatiev). NEW YORK: Havas Lynx launched a global health influencer offering last Friday, formalizing its organic community of content creators to better communicate with healthcare professionals and patients

Media 52
article thumbnail

Increase Revenue With Better, Faster Sales Onboarding

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

article thumbnail

Head and neck cancer trials 'becoming less diverse'

pharmaphorum

Despite efforts to raise diversity in clinical trials, a study in head and neck cancer found the trend in the US is going in the other direction.

74
article thumbnail

Anesthesia Sales, Surgery, And Strategy With Marie Robert

Evolve Your Success

From an internship to a full-time role at GE Healthcare, Marie Robert’s journey is anything but typical. Join us as Marie, a spirited product sales specialist, opens up about her transition from a pre-med student to thriving in the medical device sales industry, with a focus on anesthesia and perioperative equipment. Her story is a testament to the power of building strategic relationships and navigating the complexities of selling capital equipment where decision-makers are not always the

Sales 52
article thumbnail

Understanding how analytics can drive PCP growth strategy with Memorial Hermann Health System and Clarify Health

Clarify Health

Deploying Analytics to Enable Primary Care Strategy A webinar with Clarify Health and Memorial Herman in collaboration with the American Association of Physician Leadership (AAPL). “ Clarify’s platform allowed us to dive deep into our referral data and identify areas where we could better engage with providers. This, in turn, helped us strengthen those partnerships and expand our reach.

article thumbnail

Nipocalimab Demonstrates Sustained Disease Control in Adolescents with Generalized Myasthenia Gravis

PharmExec

Results from the Phase II/III Vibrance-MG study found that patients with generalized myasthenia gravis who were treated with nipocalimab plus standard-of-care achieved sustained disease control.

article thumbnail

European Clinical Supply Planning: Balancing Cost, Flexibility and Time

article thumbnail

The Role of Trademarks in the Sustainability Revolution: Insights from our recent webinar

Clarivate

Green trademarks are a powerful tool for businesses that seek to communicate their sustainability commitments to consumers. However, some businesses have also utilized these marks to influence consumer purchasing decisions without fully committing to the cause. As with all trademark applications, sustainability marks are subject to rigorous legal and regulatory scrutiny, and brand owners must navigate a complex landscape to ensure their eco-friendly claims are both genuine and legally sound.

Ethics 52
article thumbnail

LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025

Pharmaceutical Commerce

In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains.

article thumbnail

Kriyadocs Announces Strategic Collaboration With CCC to Enhance Publishing Workflows

Copyright Clearance Center

October 16, 2024 – Kriyadocs is excited to announce a new strategic collaboration with CCC , a leader in advancing copyright, accelerating knowledge, and powering innovation, that features an integration of CCC’s Ringgold Identify Database , of organization persistent identifiers (PIDs) and metadata, into the Kriyadocs Unified Publishing Ecosystem. This partnership will support publishers in significantly enhancing data accuracy and streamlining the publishing process. “We are thrilled to

article thumbnail

Highly Commended in the 2024 MCA Awards

Curzon Consulting

Highly Commended at the 2024 MCA Awards 16th October 2024 5 Minutes 10 Years of Continued Success Huge congratulations to the Curzon Consulting team – marking 10 years of continued success at last night’s MCA Awards. Amidst strong competition, we proudly secured a Highly Commended award in the Commercial Impact category. This outstanding achievement is a testament to the incredible work of the joint Marston Holdings and Curzon Consulting team, who delivered exceptional results within an im

article thumbnail

Using Generative AI in Sales: Pros, Cons, and Considerations According to Sellers

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A